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Abstract
Osteoporotic hip fracture (HF) is a serious global public health problem associated with high morbidity and mortality. Hip
bone size (BS) has been identified as one of key measurable risk factors for HF, independent of bone mineral density (BMD).
Hip BS is highly genetically determined, but genetic factors underlying BS variation are still poorly defined. Here, we
performed an initial genome-wide copy number variation (CNV) association analysis for hip BS in 1,627 Chinese Han
subjects using Affymetrix GeneChip Human Mapping SNP 6.0 Array and a follow-up replicate study in 2,286 unrelated US
Caucasians sample. We found that a copy number polymorphism (CNP267) located at chromosome 2q12.2 was significantly
associated with hip BS in both initial Chinese and replicate Caucasian samples with p values of 4.73E-03 and 5.66E-03,
respectively. An important candidate gene, four and a half LIM domains 2 (FHL2), was detected at the downstream of
CNP267, which plays important roles in bone metabolism by binding to several bone formation regulator, such as insulin-
like growth factor-binding protein 5 (IGFBP-5) and androgen receptor (AR). Our findings suggest that CNP267 region may be
associated with hip BS which might influence the FHL2 gene downstream.
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Introduction
Osteoporosis is a serious global public health problem especially
in the elderly, which is characterized by low bone mineral density
(BMD) and low trauma fracture. Osteoporotic hip fracture (HF) is
the most serious low trauma fracture with high morbidity and
mortality. It has been predicted that the number of osteoporotic
fractures (OFs) worldwide will increase to 6.3 million in 2050, with
most of these future fractures happening in Asian [1]. The
economic burden is estimated at 17 billion dollars every year on
OFs since 2005 in the United States alone [2]. Especially in recent
years, an increasing aging Chinese population has resulted in even
more OFs in China [3].
BMD, as an important risk factor for OFs, has been extensively
investigated for identifying the genetic factors underlying BMD
variation [4]. However, BMD is not the only risk factor for
osteoporotic fracture, and recent studies suggested that bone size
(BS) is another important risk factor for OFs independent of BMD
[5,6]. BS has more than 50% of heritability in both Chinese and
Caucasians [7,8]. Abnormal BS contributes significantly to the
pathogenesis of OFs [5,6]. Bigger bone size is a logical adaptation
to enhance the mechanical competence of bone, because a larger
cross-sectional area can bear larger compressive loads and cope
more efficiently with bending loading. Spine BMD in females is
comparable with that in males, however, females suffer a larger
incidence of spine fractures than males partially attributable to the
fact that female’s spine bone sizes are 20–25% smaller than male’s
after adjusting for body size differences [9]. A genetically
homogenous inbred mouse strain has higher bone mass but
smaller bone size, and is less sensitive in adapting to mechanical
loading to increase bone strength when compared with another
inbred mouse strain [10]. Currently, only a few of genes such as
VDR [11,12], ER, COL1A2 [13], CYP17 [14], PTH [15], were
tested in association with BS, and most of the genetic factors for
BS largely remain unknown.
Copy number variation (CNV) is a type of DNA variation due
to diversity in the number of copies of a DNA segment that may
range from one kilobase to several megabases in size. Copy
number polymorphisms (CNPs) refer to common CNVs that
appear to involve the same affected genomic sequence and are
PLoS ONE | www.plosone.org 1 July 2011 | Volume 6 | Issue 7 | e22035therefore consistent with a model of a genetic polymorphism.
CNVs may alter gene dosage, disrupt coding sequences, or exert
long-range positional effects on gene expression pattern outside
CNV region, consequently leading to phenotype variation [16,17].
Individuals with lower copy number of CCL3L1 [18], FCGR3B
[19] and DEFB4 [20] genes were predisposed to risk of AIDS,
immunologically mediated glomerulonephritis and Crohn disease,
respectively. Recently, our groups performed two genome-wide
CNV association studies on BMD in Chinese and Caucasian and
found CNV regions containing UGT2B17 [21] and VPS13B [22]
genes were significantly associated with BMD, respectively.
However, to the best of our knowledge, there is no reported
genome-wide CNV association research that focused on hip BS
variation.
This study performed an initial genome-wide common CNV
association analysis in 1,627 Chinese Han subjects using
Affymetrix GeneChip Human Mapping SNP 6.0 array and a
follow-up replicate study in 2,286 unrelated US Caucasians
sample, and identified CNP267 region may be associated with hip
BS, which might influence the FHL2 gene downstream.
Materials and Methods
Ethics Statement
The study was approved by the necessary institutional review
boards of all the participating institutions. Before entering the
project, all the subjects signed the informed-consent documents.
Subjects and Measurement
We first performed an initial genome-wide CNV analysis for hip
BS in 1,627 unrelated Chinese Han subjects. The most significant
results identified in Chinese sample were further replicated in an
unrelated Caucasian sample.
1) Initial study sample. The sample for the initial genome-
wideCNV analysis consisted of1,627 unrelatedChinese Hanadults
including 825 women and 802 men. All the subjects were recruited
from the cities of Xi’an/Changsha and their vicinity with the
purposes of searching for genetic factors for osteoporosis related
phenotypes (such as BMD, BS, bone geometry). In order to
minimize the confounding effects of environmental and therapeutic
factors that may influence the skeletal system, individuals with
chronic diseases and conditions that might potentially affect bone
metabolism were excluded. These diseases/conditions included
chronic disorders involving vital organs (heart, lung, liver, kidney,
and brain), serious metabolic diseases (diabetes, hypo- and hyper-
parathyroidism, etc.), other skeletal diseases (Paget disease,
osteogenesis imperfecta, rheumatoid arthritis, etc.), chronic use of
drugs affecting bone metabolism (hormone replacement therapy,
corticosteroid therapy, anti-convulsant drugs), and malnutrition
conditions (such as chronic diarrhea, chronic ulcerative colitis, etc.),
etc. In addition, subjects taking anti-bone-resorptive or bone
anabolic agents/drugs, such as bisphosphonates, were excluded
from this study.
Hip BS (total area including femoral neck, trochanter and
intertrochanter) was measured by a Hologic QDR 4500W dual-
energy X-ray absorptiometry (DXA) scanner (Hologic Corp.,
Waltham, MA). The machine was calibrated daily, and the
coefficient of variation (CV) for hip BS value, obtained from seven
individuals repeatedly measured five times, of the DXA measure-
ments was 1.18%. Height and weight were measured at the same
visit for BS measurement.
2) Caucasian replication sample. To replicate the
associations for CNPs at significant level of p,0.01, we
performed another independent study in a sample including a
total of 2,286 random Caucasian subjects (age: 51.4613.8 yrs) that
were recruited in Midwestern US in Kansas City, Missouri and
Omaha, Nebraska for osteoporosis study. All identified subjects
were US Caucasians of European origin. The BS values of total hip
were measured using DXA machines (Hologic Inc., Bedford, MA,
USA) that were calibrated daily. The CV of the DXA measurement
for total hip BS was about 1.94%.
Genotyping
1) In initial study sample. Genomic DNA was extracted
from peripheral blood leukocytes using standard protocols.
Genotyping with Affymetrix Genome-Wide Human SNP Array
6.0, whichfeatures1.8million genetic markers,includingmorethan
906,600 SNPs and more than 946,000 probes for detection of copy
number variation, was performed using the standard protocol
recommended by the manufacturer. Fluorescence intensities were
quantified using an Affymetrix array scanner 30007G. Data
management and analyses were performed using the AffymetrixH
GeneChipH Command ConsoleH Software (AGCC). Contrast
quality control (QC) threshold was set at the default value of
greater than 0.4 for sample quality control. The final average
contrast QC across the entire sample reached the high level of 2.62.
The Birdsuite package (http://www.broadinstitute.org/science/
programs/medical-and-population-genetics/birdsuite/birdsuite-0)
was used for genotype calling, genotyping quality control, and
CNV identification.
For the QC for sample, we firstly measured the copy number
estimatesofeach chromosomeandgenome-wide average(sum ofall
chromosomes), reported by the Birdseye Hidden Markov Model
[23], and removed the subjects who showed excessively high or low
estimate for copy number according to either genome-wide average
or more than 2 chromosomes (.3 standard deviations). Then, we
measured the variability of CNP and SNP probe intensities
according to each chromosome and genome-wide average (sum of
all chromosomes). We removed the subjects with excessive
variability in probe intensity according to either genome-wide
average or more than 2 chromosomes (.3 standard deviations). We
kept the subjects who only had 1 or 2 chromosomes failing in copy
number estimate QC and probe intensity QC, and treated the
CNPs in the chromosomes of those subjects as missing data in
further association analysis. As a result, 1,531 samples were used in
CANARY software [23] for CNP call.
For the QC for CNPs, we removed the CNPs withmorethan 5%
of uncertain or missing copy call (CC) or with less than 1% of allele
frequency (AF) that refers to the total proportion of the subjects with
copy number less or more than two in total sample. Of the initial
full-set of 1,316 CNPs, there are 817 CNPs with AF ,1%, 735
CNPs with CC greater than 0.05 and 430 CNPs with both. Finally
194 CNPs covering ,12 Mb with an average marker spacing of
64 kb remain in the final association analyses (Table S1).
2) In replication sample. Genomic DNA was extracted
from human blood using a commercial isolation kit (Gentra
systems, Minneapolis, MN, USA) following the protocols detailed
in the kit. Genotyping and quality control procedures are the same
as in Chinese.
Statistical analysis
We used stepwise regression model to screen significant
covariates for each study cohort. Parameters including age, age
2,
sex, age-sex, age
2-sex, weight, height, BMI, birth year were tested
for their association with hip BS. Significant (p#0.05) parameters
(weight, height in initial Chinese sample and age, sex, age-sex, age
2-
sex, height, birth year in replication Caucasian sample) were then
included as covariates to adjust the raw BS values. EIGENSTRAT
CNV and Bone Size
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for stratification in genome-wide association studies [24]. We used
,370,000 SNPs to calculate the principal components and the ten
default main eigenvectors were used as covariates to adjust the raw
BS values for correction of population stratification. The adjusted
BS data, if not following normal distributions, were further
subjected to BoxCox transformation into normal distribution.
Finally, association analyses between CNPs and hip BS were
performed using the PLINK software package (version 1.07)
(http://pngu.mgh.harvard.edu/,purcell/plink/).
The CNPs at the significant level of p,0.01 identified in
Chinese sample were selected in replication study in Caucasian.
The processes of raw hip BS value adjustment and association
analyses in replication study were the same as in initial discovery
study in Chinese.
Results
The basic characteristics of the subjects used in association
analyses and replication analyses, including sex, age, height,
weight, hip BS were summarized in Table 1.
In the initial genome-wide CNV analysis in Chinese sample,
four CNPs were associated with hip BS at significant level of
p,0.01 (CNP11164 P=6.18E-04, CNP182 P=1.05E-03,
CNP267 P=4.73E-03, CNP10799 P=7.23E-03) (Table 2). To
find replication association evidence, we performed a subsequent
replication analysis for these four CNPs in Caucasians that have
evidently different genetic background from Chinese. Due to AF of
CNP11164 (AF=0.0031) and CNP10799 (AF=0.003) is smaller
than 1%, only CNP182 and CNP267 were analyzed for replicate
association and reached p values at 2.39E-01 and 5.66E-03,
respectively (Table 2). Meta-analysis (Fisher’s combined p method
[25]) was used to combine association tests in the two populations.
The Fisher’s combined p value (p=3.09E-04) for CNP267 is
nearly approaching the significant level after multiple testing
(0.05/194=2.58E-04).
CNP267 was located in 2q12.2 with physical position from
106,247,145 bp to 106,251,789 bp. The four and a half LIM
domains 2 (FHL2) located at the downstream of CNP267, is an
important candidate gene, which plays important roles in bone
metabolism by binding to several bone formation regulator (details
in Discussion). Of the subjects analyzed in the initial and
replication samples, carriers of copy number (CN) of 0CN,
1CN, 2CN and 3CN, were 210, 669, 513, 5 in Chinese sample
and 214, 910, 914, 7 in Caucasian sample, respectively. Cause the
number of carriers of CN=3 is too small to be statistic significant,
we excluded the data of CN=3 in the following analysis. For the
effect of CNP267, we compared the adjusted hip BS for subjects
with different CNs of CNP267 in both the initial and replication
studies. As shown in Figure 1, CN was negatively associated with
hip BS in Chinese sample (i.e., individuals with more CNs trend to
have lower hip BS), but positively in Caucasian sample. The
opposite effect of CN on BS variation may be caused by several
reasons (details in Discussion). Regression analysis showed that
CNP267 can explain ,0.97% of hip BS variation.
Discussion
CNV is a type of recently increasingly being recognized DNA
variation associated with human complex diseases. CNV presum-
ably alters gene dosage, disrupts coding sequences, or exerts long-
range positional effects on the gene expression pattern outside the
Table 1. Basic characteristics of the study subjects.
Trait Initial Chinese sample Caucasian replication sample
Total (N=1,627) Male (N=802) Female (N=825) Total(N=2281) Male(N=555) Female(N=1726)
Age(year) 34.45 (13.23) 31.43 (11.93) 37.39 (13.76) 51.33(13.74) 50.62(16.04) 51.56(12.91)
Height(cm) 164.25 (8.16) 170.28 (5.95) 158.38 (5.22) 166.35(8.47) 175.87(7.24) 163.29(6.27)
Weight(kg) 60.09 (10.48) 65.72 (9.63) 54.61 (8.09) 75.26(17.53) 87.08(16.72) 71.46(16.04)
Hip BS (cm
2) 34.05 (5.71) 38.01 (4.01) 30.20 (4.30) 38.35(6.37) 45.86(5.84) 35.93(4.32)
Note: Presented as means (SD).
doi:10.1371/journal.pone.0022035.t001
Table 2. Characteristics of the interesting CNPs for association analysis.
NAME Chr Start End Initial Chinese sample Caucasian replication sample Combined P-value
P value AF CC P value AF CC
CNP267 2 106247145 106251789 4.73E-03 0.6328 0.0129 5.66E-03 0.5549 0.0182 3.09 E-04
CNP182 1 246815817 246863836 1.05E-03 0.3055 0.0030 2.39E-01 0.2686 0.0053 2.33 E-03
CNP11164 6 162658558 162660430 6.18E-04 0.1081 0.0441 N/A 0.0031 0.0364 N/A
CNP10799 4 138543995 138549443 7.23E-03 0.0103 0.0478 N/A 0.0030 0.0205 N/A
Note:
1. AF: allele frequency is calculated as the total proportion of subjects with copy number less or more than two in total samples; CC: uncertain or missing copy calls of
CNPs; N/A:not available.
2. This table only lists the association information for 4 interesting CNPs with p,0.01 in the initial genome-wide CNV association analysis, and the information for other
190 CNPs with p.0.01 was presented in the Table S1. Due to the low AF of last two CNPs in replication sample, no association analysis was performed.
3. Combined p value: Fisher’s combined p method [25] was used to combine association tests in the two populations.
4. The NCBI reference genome is Bulid 36.1.
doi:10.1371/journal.pone.0022035.t002
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performed the first genome-wide CNV association study in a large
Chinese sample for an important bone strength phenotype, hip
BS, and a follow-up replicate study in 2,286 unrelated US
Caucasians sample, and identified that CNP267 region may be
associated with hip BS. We also tried to find if there are any BS
candidate genes in the regions of significant CNPs in initial
Chinese sample. Although there were no well known BS candidate
genes, such as VDR, ER, COL1A2, CYP17, PTH et al., we
suggested that these genes should deserve more attention in further
studies and presented the results in Table S2.
CNP267 was located in 2q12.2 with physical position from
106,247,145 bp to 106,251,789 bp, where no important candidate
gene has known function directly associated with osteoporosis or
bone. However in the downstream of CNP267 there is an
important candidate gene, the four and a half LIM domains 2
(FHL2), which plays important roles in bone metabolism by
binding to several bone formation regulator. FHL2 is strongly
expressed in all types of human osteoblasts [26]. FHL2 can bind to
several regulation factors that are important during bone
formation. For example, it binds to insulin-like growth factor-
binding protein 5 (IGFBP-5) [26], the most abundant IGFBP
stored in bone, which plays an important role in regulating bone
formation [27,28,29,30]. FHL2 also increases transcriptional
activity of androgen receptor (AR) [31], which is important in
regulation of bone formation and resorption [32,33]. In addition,
FHL2 can also influence bone formation as one of modulators of
the Wnt signaling pathway [34,35] and TNF receptor–associated
factor 6 (TRAF6)-mediated receptor activator of NF-kB (RANK)
signaling pathway [36]. Gene knockdown studies showed that
FHL2-deficient mice have decreased BMD and BS due to
decreased osteoblast activity [37,38]. Conversely, enforced ex-
pression of FHL2 boosts mineralization in cell culture and
increased bone mass in transgenic mice [37].
Genes located outside of CNV intervals can show disrupted
expression patterns by long-range position effects. For example,
transcription levels of some genes located in the diploid flanking
sequence outside deletion region were altered in patients carrying
the Williams-Beuren syndrome deletion [39]. CNV17p11.2 can
change the expression of some flanking genes, and thus cause
Smith-Magenis syndrome [40]. Whole genome association studies
between CNVs and gene expression levels showed that more than
half of identified genes significantly associated with CNVs were
not located in the CNV intervals [41]. These observations may
change the traditional view, i.e., CNVs regulate gene expression
via directly altering copy number of dosage-sensitive genes located
in CNV intervals. However CNVs may alter the expression of
genes located outside of CNV intervals by disrupting local
chromatin environment and/or gene regulatory elements such as
enhancers, silencers, and insulators. Previous studies reported that
the relative expression levels of genes were modified through
changes in copy numbers as far as 2–7 Mb away from the
breakpoints [41,42].
In association study, the inconsistence of association directions
between initial and replicate association studies is usually observed.
There may be several reasons to address the opposite effect of CN
on BS variation. First, it is well known that the same risk locus with
diverse genetic background may generate different effects [43,44].
Studies also showed that osteoporosis related phenotypes are
clearly under ethnic specific genetic determination [45,46,47].
Chinese and Caucasians are two evidently different populations in
genetic background. The comparison of frequencies of CNs in the
two samples shows significantly different with P,0.01 in chi-
square test. The ethnic difference may lead to the reverse effect of
association in our study. Second, in most situations, significant
association suggests strong linkage disequilibrium between marker
and causal locus. If the causal loci are different in two samples, it is
possible to cause discordant direction of association. For example,
the risk allele of marker is negatively correlated with a risk allele at
one causal locus in one population, but positively associated with a
protective allele at another causal locus in another population.
Czarnomska et al. also reported such observation, i.e., a set of
Figure 1. Hip BS values in groups with different copy number (CN) of CNP267 in the Chinese and Caucasians. Data presented are
adjusted mean (SE: standard error) [observation number]; CN: copy number.
doi:10.1371/journal.pone.0022035.g001
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but with opposite effects [48]. Finally, environmental covariates
may influence the effect direction of gene variants. Eder et al.
discovered opposite effects of CD14/2260 on serum IgE levels in
children raised in different environments [49]. Reneland et al.
found that rs1498608 in PDE4D gene showed an opposite
relationship with BMD variation, which indicating that the
variant’s effect may be context-dependent [50]. The two samples
come from different geographic regions, suggesting obviously
different environment such as living condition and dietary habit.
These differences may also influence the effect direction of the
allele.
In this study, FHL2 may be recognized as an important
candidate gene involved in the association between CNP267 and
hip BS by the potential mechanism that CNP267 may influence
the expression of FHL2 by causing changes in local chromatin
structure or alterations in enhancer activity. This potential
mechanism is waiting for being confirmed by functional studies.
In conclusion, this is the first genome-wide CNV association
study for hip BS in Chinese Han sample. CNP267 was
significantly associated with hip BS in both Chinese and
Caucasian. Our findings suggest that CNP267 region may be
associated with hip BS.
Supporting Information
Table S1 Information of other 190 CNPs with p.0.01 in
initial Chinese association analysis.
(DOC)
Table S2 Candidate genes at the interesting CNP
regions in initial Chinese sample.
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